Impact of concomitant administration of gastric acid-suppressive agents and pazopanib on outcomes in soft-tissue sarcoma patients treated within the EORTC 62043/62072 trials

Mir, O., Touati, N., Lia, M. et al. (11 more authors) (2019) Impact of concomitant administration of gastric acid-suppressive agents and pazopanib on outcomes in soft-tissue sarcoma patients treated within the EORTC 62043/62072 trials. Clinical Cancer Research, 25 (5). pp. 1479-1485. ISSN 1078-0432

Abstract

Metadata

Authors/Creators:
  • Mir, O.
  • Touati, N.
  • Lia, M.
  • Litière, S.
  • Le Cesne, A.
  • Sleijfer, S.
  • Blay, J.-Y.
  • Leahy, M.
  • Young, R.
  • Mathijssen, R.H.J.
  • Van Erp, N.P.
  • Gelderblom, H.
  • Van der Graaf, W.T.
  • Gronchi, A.
Copyright, Publisher and Additional Information: © 2019 American Association for Cancer Research. This is an author produced version of a paper subsequently published in Clinical Cancer Research. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 14 December 2018
  • Published (online): 14 February 2019
  • Published: March 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 06 Mar 2019 11:24
Last Modified: 14 Feb 2020 01:39
Published Version: https://doi.org/10.1158/1078-0432.CCR-18-2748
Status: Published
Publisher: American Association for Cancer Research
Refereed: Yes
Identification Number: https://doi.org/10.1158/1078-0432.CCR-18-2748
Related URLs:

Share / Export

Statistics